Connection
David Binder to Biomarkers
This is a "connection" page, showing publications David Binder has written about Biomarkers.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.020 |
|
|
|
-
Zhai L, Ladomersky E, Lauing KL, Wu M, Scholtens DM, Savoor R, Zhang B, Wu JD, Horbinski C, Lukas RV, Binder DC, Wainwright DA. Commentary: preclinical efficacy of immune-checkpoint monotherapy does not recapitulate corresponding biomarkers-based clinical predictions in glioblastoma by Garg et al. (2017). Oncoimmunology. 2019; 8(3):1548242.
Score: 0.020